Sreek Vemulapalli and Roseann White explain the statistical challenges that can arise while collecting longer-term follow-up data during clinical trials.

Sreekanth Vemulapalli asks Ryan Ahern about potential data sources that can be used to sustain long-term follow-up in pivotal trials.

Vinod Thourani and Larry Epstein explore the current field of tricuspid intervention as well as challenges within lead management with additional commentary from Ami Bhatt.

Paul Sorajja and Vinod Thourani discuss the key considerations for choosing between transcatheter tricuspid repair and replacement.

Janar Sathananthan, Ole De Backer, and Michael Reardon dive into the newest findings on TAVR from the late-breaking ACURATE IDE trial.

Ami Bhatt asks Kate Dalton to share details on the challenges of early feasibility studies from her perspective as a clinical site coordinator.

Ami Bhatt and Michael Mack explore the ethics of AI use in the detection of subclinical cardiovascular disease.

Ami Bhatt and Michael Mack explain the economics of AI use in the detection of subclinical cardiovascular disease.

Ami Bhatt and Martin Leon discuss the critical importance of early feasibility studies in the US clinical community.

Michael Mack speaks with Stefan Anker about the outcomes and implications of the RESHAPE-HF2 trial.